Nectin-2 is a potential target for antibody therapy of breast and ovarian cancers

Tsutomu Oshima(Takeda (Japan)), Toshio Kokubo(University of Tsukuba), Isamu Tsuji(Takeda (Japan)), Junichi Kato(Hiroshima University), Takahiro Watanabe(Nagoya University), Shuji Sato(Obihiro National Hospital), Akira Hori(Takeda (Japan)), Tomofumi Kurokawa(Taisho Pharmaceutical (Japan)), Yuki Ito(Anjo Kosei Hospital)
Molecular Cancer
June 12, 2013
Cited by 111


Related Papers